Listed by:


Established in 1999, this Midwest-based “specialty” pharmacy generated over $6.5M of gross revenue, EBITDA of $475K, and SDE cash flow of $575K in FY2010. YTD2011 performance places the pharmacy on track to generate +$7.0M of gross annual revenue, and EBITDA of +$525K, SBA-adjusted Cash Flow of $585K, and SDE Cash Flow of +$745K.
Staffed with one F/T RPh, two F/T RxTechs, and one F/T General Manager, this company operates under a lean, highly efficient business plan. This is an ideal acquisition candidate for the Purchaser that is seeking to diversify/expand OR that is seeking to conduct a merger/consolidation.
Seller’s asking price of $2.9M + inventory at seller’s cost (approx. $80K) includes FF&E valued at $30,000. Funding project for this business acquisition has been pre-approved by an SBA-preferred lender with 12.5% buyer equity.
For additional information, please contact either David Hayes at ------------ Ext. 241 (---------@--------------.---) -- ---- ------ -- ------------ ---. --- (----.------@--------------.---).
Limited Free Trial Available.
If you own a business and are considering selling, visit our Sell a Drug Store / Pharmacy section.



Advertisement